Registered charity No. 1174127

Bridging the Gap: Why the BSRA is Building Stronger Ties with Industry

For almost 100 years, the British Society for Research on Ageing (BSRA) has been the cornerstone of the UK’s geroscience community, funding and championing the fundamental biology of ageing. Our core mission remains firmly rooted in peer-reviewed, rigorous academic science. However, understanding the mechanisms of ageing is only the first step; translating those discoveries into the tangible impact of healthspan extension requires a robust, interconnected ecosystem.

Basic science does not happen in a vacuum. Moving from bench to bedside requires specialized equipment, translational pathways, and a seamless two-way movement of science, concepts, and talent. This is why the BSRA is actively expanding our engagement with biotech, pharmaceutical and nutraceutical companies, and laboratory suppliers. As one example of this, in November 2026 we were pleased to have a team of 3 BSRA trustees attend the Nutra Healthspan conference in London. Emeritus Chair David Weinkove opened the conference with a talk entitled ‘The Challenge and Opportunity of our Ageing Population’ whilst Chair Bradley Elliottt & Industry Engagement trustee Diana Marcu staffed a booth and engaged with industry attendees on the work of the BSRA, how we can mutually help out on our mission to support healthy life expectancy, and how supporting the BSRA can benefit their organisations. 

We are building structured corporate partnerships as these are mutually beneficial. Aligning academic research with industry capabilities accelerates discovery, but also because the BSRA provides unique, reciprocal value to the commercial sector in four vital ways.

Equipping the Frontlines of Discovery

Like theoretical vs applied physics, we are approaching an era of ‘theoretical biology’ where biological breakthroughs and testing of hypotheses are increasingly bottlenecked by technological advancements in sequencing sensitivities, novel tools, or specialised techniques. We want our researchers equipped with the best possible tools. By inviting industry to sponsor our Small Research Grants or exhibit at our Annual Scientific Meeting (ASM), we facilitate direct access between the developers of cutting-edge laboratory technologies and the early-career researchers (ECRs) who rely on them. For industry, this provides an unparalleled, highly focused environment to both see the needs of, and showcase platforms directly to, the laboratory users and decisionmakers actively pushing the boundaries of geroscience.

Nurturing and Connecting Scientific Talent

A core pillar of the BSRA’s mission is supporting ECRs. The biopharma industry is simultaneously facing a critical need for highly specialized talent in cellular senescence, bioinformatics, and translational biology. We view this as a natural synergy. We invite industry partners to sponsor our career milestones such as the Korenchevsky Award for oral presentations, poster prizes, and summer studentships. This funding directly supports our emerging scientists, while giving corporate recruiters exclusive, early visibility of the UK’s top geroscience talent before they enter the broader job market.

Accelerating Translation from Bench to Clinic

To see our academic findings translated into real-world impacts, the commercial sector needs visibility into early-stage research. The BSRA’s academic seminar series and the ASM serve as the premier venues for sharing preliminary data and novel biological findings. We encourage venture capital teams, R&D scouts, and biotech developers to engage with these events. Doing so provides them with a front-row seat to the fundamental science that will eventually form the basis of new intellectual property, strategic partnerships, and biotech spinouts.

Fostering Meaningful Scientific Dialogue

The BSRA is fiercely protective of our academic integrity; our main conference stages are strictly reserved for peer-reviewed science, not commercial presentations. However, we recognize that our academics benefit immensely from understanding the new platforms and methodologies being developed in the private sector. To bridge this, we are happy to host industry-supported events such as sponsored lunchtime workshops, meet-and-greet opportunities, and hosted coffee-break discussion groups. These focused sessions allow companies to share data on novel biomarker screening tools or AI-driven discovery platforms, validating their technologies through direct, face-to-face dialogue with key opinion leaders in a collaborative rather than a purely commercial setting.

Ultimately, turning the Geroscience hypothesis of ageing into measurable improvements in society’s healthy life expectancy requires both academic rigor and commercial scale. By formalizing our corporate partnerships, the BSRA is ensuring that the UK remains at the absolute forefront of the geroscience revolution.

Organizations interested in joining this ecosystem and supporting the future of ageing research can explore our partnership opportunities by contacting industry partnerships trustee Dr Diana Marcu at Diana.Marcu@BSRA.org.uk.

AgencyForGood

Copyright 2026. All Rights Reserved